Robert L. Camp
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
Papers in
-
- Gene expression and cancer classification 14
- Advanced Biosensing Techniques and Applications 10
- Glycosylation and Glycoproteins Research 8
- Oncology 56
- HER2/EGFR in Cancer Research 26
- Co-authors
- David L. Rimm (78 shared papers)Marisa Dolled‐Filhart (12 shared papers)Gina G. Chung (10 shared papers)Harriet M. Kluger (35 shared papers)Lori A. Charette (4 shared papers)Ellen Puré (6 shared papers)Diane Kowalski (11 shared papers)Amanda Psyrri (11 shared papers)
- Journals
- Clinical Cancer Research (19 papers)Cancer (11 papers)Journal of Clinical Oncology (10 papers)Cancer Research (7 papers)Laboratory Investigation (6 papers)
- Partner nations
- United StatesCanadaGreece
In The Last Decade
Robert L. Camp
118 papers receiving 12.6k citations
Robert L. Camp's Hit Papers
Peers
Comparison fields: 5 of 150
- Oncology 5.7k
- Otorhinolaryngology 776
- Cancer Research 2.4k
- Immunology and Allergy 658
- Molecular Biology 6.2k
Countries citing papers authored by Robert L. Camp
This map shows the geographic impact of Robert L. Camp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Camp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Camp more than expected).
Fields of papers citing papers by Robert L. Camp
This network shows the impact of papers produced by Robert L. Camp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Camp. The network helps show where Robert L. Camp may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert L. Camp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | X-Tile Hit paper breakdown → | 2004 | 2916 |
| 2 | Validation of Tissue Microarray Technology in Breast Carcinoma Hit paper breakdown → | 2000 | 655 |
| 3 | Automated subcellular localization and quantification of protein expression in tissue microarrays Hit paper breakdown → | 2002 | 645 |
| 4 | Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis Hit paper breakdown → | 2006 | 618 |
| 5 | 2003 | 288 | |
| 6 | 2007 | 266 | |
| 7 | 2011 | 260 | |
| 8 | 2005 | 229 | |
| 9 | 2001 | 219 | |
| 10 | 2005 | 211 | |
| 11 | 1993 | 207 | |
| 12 | 2008 | 206 | |
| 13 | Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. | 2003 | 197 |
| 14 | Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. | 2003 | 184 |
| 15 | Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. | 2002 | 165 |
| 16 | Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. | 2003 | 163 |
| 17 | 2006 | 153 | |
| 18 | 2008 | 151 | |
| 19 | 2012 | 148 | |
| 20 | 1999 | 140 |
About Robert L. Camp
Robert L. Camp is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 118 papers that have together received 12.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (26 papers), Gene expression and cancer classification (14 papers), Cell Adhesion Molecules Research (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Renal cell carcinoma treatment (10 papers), Advanced Biosensing Techniques and Applications (10 papers), Breast Cancer Treatment Studies (9 papers) and Glycosylation and Glycoproteins Research (8 papers). The work is most often cited by research in Oncology (5.7k citations), Otorhinolaryngology (776 citations), Cancer Research (2.4k citations), Immunology and Allergy (658 citations) and Molecular Biology (6.2k citations). Robert L. Camp has collaborated with scholars based in United States, Canada and Greece. Frequent co-authors include David L. Rimm, Marisa Dolled‐Filhart, Gina G. Chung, Harriet M. Kluger, Lori A. Charette, Ellen Puré, Diane Kowalski, Amanda Psyrri, Bruce G. Haffty and Ziwei Yu. Their work appears in journals such as Clinical Cancer Research, Cancer, Journal of Clinical Oncology, Cancer Research and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.